Home pageNVZMY • OTCMKTS
add
Novozymes
Chiusura precedente
65,95Â $
Intervallo giornaliero
65,25Â $ - 65,80Â $
Intervallo annuale
38,83Â $ - 72,50Â $
Cap di mercato
187,29Â Mrd DKK
Volume medio
9095,00
Dati finanziari
Conto economico
Entrate
Utile netto
| (EUR) | giu 2024info | Variazione Y/Y |
|---|---|---|
Entrate | 915,85Â Mln | 61,70% |
Spese di gestione | 271,75Â Mln | 52,62% |
Utile netto | 31,95Â Mln | -60,72% |
Margine di profitto netto | 3,49 | -75,70% |
Utili per azione | — | — |
EBITDA | 150,94Â Mln | -16,50% |
Aliquota fiscale effettiva | 29,00% | — |
Stato patrimoniale
Totale attivo
Totale passivo
| (EUR) | giu 2024info | Variazione Y/Y |
|---|---|---|
Investimenti cash/breve termine | 260,80Â Mln | 85,35% |
Totale attivo | 15,25Â Mrd | 302,43% |
Totale passivo | 4,25Â Mrd | 119,23% |
Patrimonio netto totale | 11,00 Mrd | — |
Azioni in circolazione | 277,90 Mln | — |
Prezzo/valore contabile | 1,67 | — |
Redditività dell'attivo | 1,83% | — |
Rendimento sul capitale | 2,15% | — |
Flusso di cassa
Flusso di cassa netto
| (EUR) | giu 2024info | Variazione Y/Y |
|---|---|---|
Utile netto | 31,95Â Mln | -60,72% |
Liquidità di esercizio | 264,05 Mln | 74,01% |
Contanti da investimenti | -27,45Â Mln | 70,98% |
Contanti da finanziamenti | -186,70Â Mln | -205,10% |
Flusso di cassa netto | 55,55Â Mln | 902,56% |
Flusso di cassa libero | -17,57Â Mln | 68,87% |
Informazioni
Novozymes A/S was a global biotechnology company headquartered in Bagsværd, outside of Copenhagen, Denmark. The company's focus was the research, development and production of industrial enzymes, microorganisms, and biopharmaceutical ingredients. The company merged with Chr. Hansen to form Novonesis in January 2024.
Prior to the merger, the company had operations around the world, including in China, India, Brazil, Argentina, United Kingdom, the United States, and Canada. Class B shares of its stock were listed on the NASDAQ OMX Nordic exchange.
On 12 December 2023, it was announced that Novozymes and Danish bioscience company Chr. Hansen had obtained regulatory approval for a merger, and on the following day, the name of the combined company was revealed as Novonesis. Wikipedia
CEO
Fondazione
2000
Sito web
Dipendenti
10.452
